Basis for innovation
The FiZ

The FiZ Frankfurt Biotechnology Innovation Center is a market-oriented technology center operated under a public-private partnership. It offers small and medium-sized business in the life sciences field a unique basis for innovation and growth. Support is provided on two levels: by the infrastructure of the FiZ campus and through the initiatives and networks of the FiZ synergy projects. 

Dr. Christian Garbe

Managing Director

Dr. Christian Garbe has been the Managing Director of FiZ Frankfurter Innovationszentrum Biotechnologie GmbH since its founding in 2002. He completed his studies in agricultural sciences at Georg-August University in Göttingen and earned his doctorate in 1996 with emphasis in economics and social sciences. Subsequently, Dr. Christian Garbe began his professional career at Novartis in Basel, where he assessed potentials of biotechnology for product developments. After transitioning to DZ BANK AG in Frankfurt, he analyzed pharmaceutical and biotechnology companies there and successfully managed a biotech fund.

The focus of his work is in the development of international business models and innovative, data-driven technologies. In doing so, he consistently implements the megatrend of digitalization and the topic of industry 4.0, in which processes are digitized in a platform-based manner and used in practical applications.

Raphael Schlappa

Director of Finance & Operations

Being at FiZ since 2006, Raphael Schlappa has been managing the departments of finance, HR, IT, and real estate management as the Director of Finance & Operations and authorized representative since 2012. He completed his studies in economics with the degree of Diplom-Ökonom (Certified Economist) at the University of Hohenheim. During his studies, Raphael Schlappa had already held positions at Daimler Chrysler AG in the area of controlling and human resources in Stuttgart and Dubai. He was subsequently employed with a management consulting firm prior to moving to the Rhein-Main area.

The Supervisory Board of FiZ

The shareholders of FiZ GmbH, founded in 2002, are the state of Hesse, the city of Frankfurt am Main and the Chamber of Industry and Commerce of Frankfurt am Main. According to the shareholder agreement, the purpose of the company  is to support the development of the biotechnology economy in the Rhine Main Region, to promote and maintain the biotechnology potential available in the region, to establish companies in the biotechnology area in the region, and to create qualified jobs in this area, in particular through the operation of a center for biotechnology-oriented business start-ups and companies.

State Minister Prof. Dr. Kristina Sinemus 
State Minister at the Ministry of Digital Strategy and Development (Chairman)

City Councilor Stephanie Wüst
Head of Department for Economics, Law and Reforms of the City of Frankfurt am Main (Deputy Chairman)

City Treasurer Dr. Bastian Bergerhoff
City Treasurer and Head of Department for Finances, Investments and Personell of the City of Frankfurt am Main

Ulrich Caspar
President of Chamber of Industry and Commerce Frankfurt am Main 

State Minister Angela Dorn
State Minister at the Ministry of Science and Art of the State of Hesse 

Dr. Anna Carina Eichhorn 
Executive Board Humatrix AG

City Councilor Ina Hauck
The Magistrate of the City of Frankfurt am Main

Prof. Dr. Sven Klimpel
Dean of the Faculty of Biosciences, Goethe University Frankfurt am Main 

Dr. Thomas Steigleder
Managing Director of the Frankfurt am Main Chamber of Commerce and Industry

State Secretary Dr. Martin J. Worms
Hessian Ministry of Finance


Details as per § 5 TMG

Operator and contact details
FiZ Frankfurter Innovationszentrum Biotechnologie GmbH
Altenhöferallee 3
60438 Frankfurt am Main GERMANY

Phone: +49 (0) 69 800 865-0
Fax: +49 (0)69 800 865 19
Email: info( at )

FiZ Frankfurter Innovationszentrum Biotechnologie GmbH is represented by
Dr. Christian Garbe
Registry and registry number: Frankfurt am Main HRB 55518

VAT ID no.:

Publication details on this website created using the generator of the Deutsche Anwaltshotline AG